Infections and Cancer Epidemiology group, International Agency for Research on Cancer, Lyon, France.
Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
Int J Cancer. 2017 Nov 15;141(10):1997-2001. doi: 10.1002/ijc.30901. Epub 2017 Aug 10.
The vast majority (86% or 453,000 cases) of the global burden of cervical cancer occurs in Africa, Latin America and the Caribbean and Asia, where one in nine new cancer cases are of the cervix. Although the disease has become rare in high-resource settings (e.g., in North America, parts of Europe, Japan) that have historically invested in effective screening programs, the patterns and trends are variable elsewhere. While favourable incidence trends have been recorded in many populations in Asia and Latin America and the Caribbean in the past decades, rising rates have been observed in sub-Saharan African countries, where high quality incidence series are available. The challenge for countries heavily affected by the disease in these regions is to ensure resource-dependent programmes of screening and vaccination are implemented to transform the situation, so that accelerated declines in cervical cancer are not the preserve of high-income countries, but become the norm in all populations worldwide.
全球 86%(453,000 例)的宫颈癌负担发生在非洲、拉丁美洲和加勒比地区以及亚洲,每九个新增癌症病例中就有一个是宫颈癌。尽管在历史上投资于有效筛查计划的高资源环境中(例如北美、欧洲部分地区、日本),这种疾病已变得罕见,但在其他地方的模式和趋势是可变的。尽管在过去几十年中,亚洲和拉丁美洲及加勒比地区的许多人群中记录到了有利的发病率趋势,但在有高质量发病率系列数据的撒哈拉以南非洲国家中,发病率呈上升趋势。对于这些地区受该疾病严重影响的国家来说,面临的挑战是确保实施依赖资源的筛查和疫苗接种计划,以改变这种局面,使宫颈癌的发病率迅速下降不仅是高收入国家的专利,而是成为全世界所有人群的常态。